Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
glucosuria threshold | blood glucose concentration at which glucose begins appearing in urine under the stated conditions | The glucosuria threshold was discussed in light of the current medication. | Objective | Glucose monitoring, endocrine testing and urine studies |
C-peptide | peptide released with endogenous insulin and used to assess endogenous insulin production | C-peptide was interpreted with the paired glucose and kidney function. | Objective | Glucose monitoring, endocrine testing and urine studies |
insulin antibody | antibody directed against insulin | The insulin antibody was reported with the treatment history and testing indication. | Objective | Glucose monitoring, endocrine testing and urine studies |
islet autoantibodies | antibodies against specified pancreatic islet targets | Islet autoantibodies were reviewed individually with the assay results. | Objective | Glucose monitoring, endocrine testing and urine studies |
GAD65 antibody | antibody to glutamic acid decarboxylase 65 | The GAD65 antibody was documented with the testing indication and reference interval. | Objective | Glucose monitoring, endocrine testing and urine studies |
glycated albumin | proportion of albumin modified by glucose | Glycated albumin was reviewed with the history of altered albumin turnover. | Objective | Glucose monitoring, endocrine testing and urine studies |
thyroid-stimulating hormone | pituitary signal that regulates thyroid hormone production | Thyroid-stimulating hormone was interpreted with free thyroxine and the medication history. | Objective | Glucose monitoring, endocrine testing and urine studies |
free thyroxine | unbound fraction of the thyroid hormone T4 | Free thyroxine was reported with the method-specific reference interval. | Objective | Glucose monitoring, endocrine testing and urine studies |
total triiodothyronine | combined bound and unbound circulating T3 | Total triiodothyronine was assessed alongside the thyroid panel. | Objective | Glucose monitoring, endocrine testing and urine studies |
thyroid peroxidase antibody | antibody against thyroid peroxidase associated with thyroid autoimmunity | The thyroid peroxidase antibody was documented with the result and assay cutoff. | Objective | Glucose monitoring, endocrine testing and urine studies |
thyroglobulin antibody | antibody to thyroglobulin that can affect interpretation of some thyroglobulin assays | The thyroglobulin antibody was measured with the thyroglobulin result. | Objective | Glucose monitoring, endocrine testing and urine studies |
TSH receptor antibody | antibody binding the receptor for thyroid-stimulating hormone | The TSH receptor antibody was reviewed alongside the thyroid hormone measurements. | Objective | Glucose monitoring, endocrine testing and urine studies |
thyroglobulin level | concentration of a protein made by thyroid follicular cells | The thyroglobulin level was interpreted with thyroid history and antibody status. | Objective | Glucose monitoring, endocrine testing and urine studies |
morning cortisol | cortisol concentration from a sample collected in the morning | Morning cortisol was documented with the exact clock time and steroid exposure. | Objective | Glucose monitoring, endocrine testing and urine studies |
ACTH stimulation test | cortisol response measured before and after administration of synthetic ACTH | The ACTH stimulation test was reported with the assay and sampling schedule. | Objective | Glucose monitoring, endocrine testing and urine studies |
dexamethasone suppression test | assessment of cortisol suppression after a specified dexamethasone regimen | The dexamethasone suppression test was documented with dose timing and collection time. | Objective | Glucose monitoring, endocrine testing and urine studies |
late-night salivary cortisol | saliva cortisol measured at the specified late-night collection time | Late-night salivary cortisol was reviewed with the patient's usual sleep schedule. | Objective | Glucose monitoring, endocrine testing and urine studies |
urinary free cortisol | unbound cortisol excreted over a specified timed urine collection | Urinary free cortisol was reported with duration and assessment of collection completeness. | Objective | Glucose monitoring, endocrine testing and urine studies |
aldosterone-renin ratio | aldosterone concentration divided by a stated renin measure | The aldosterone-renin ratio was recorded with units, posture and relevant medicines. | Objective | Glucose monitoring, endocrine testing and urine studies |
plasma renin activity | measure of angiotensin I generation under specified assay conditions | Plasma renin activity was identified separately from a direct renin concentration. | Objective | Glucose monitoring, endocrine testing and urine studies |
plasma free metanephrines | circulating free catecholamine metabolites used in an endocrine evaluation | Plasma free metanephrines were documented with the collection conditions. | Objective | Glucose monitoring, endocrine testing and urine studies |
urinary fractionated metanephrines | separate measurements of urinary metanephrine metabolites | Urinary fractionated metanephrines were reviewed with collection duration and completeness. | Objective | Glucose monitoring, endocrine testing and urine studies |
insulin-like growth factor 1 | circulating marker influenced by growth hormone and other factors | Insulin-like growth factor 1 was interpreted against the age-specific reference interval. | Objective | Glucose monitoring, endocrine testing and urine studies |
parathyroid hormone concentration | measured circulating hormone regulating calcium and phosphate | The parathyroid hormone concentration was assessed with concurrent calcium, phosphate and kidney function. | Objective | Glucose monitoring, endocrine testing and urine studies |
25-hydroxyvitamin D | circulating vitamin D metabolite commonly used to assess vitamin D status | 25-hydroxyvitamin D was reported separately from the active vitamin D metabolite. | Objective | Glucose monitoring, endocrine testing and urine studies |